EUVIMEDEUVIMED entdecken
Crossref

Outcomes of SARS-CoV-2 infection post-solid organ transplantation in the cystic fibrosis population

Julie Semenchuk, Yumi Naito, Susan C Charman, Siobhán B Carr, Jamie Duckers, Stephanie Y Cheng, Bruce C Marshall, Albert Faro, Alexander Elbert, Christopher H Goss, Pierre-Régis Burgel, Carla Colombo und 14 weitere

Journal of Cystic Fibrosis · 2026-07 · 25 (4) · 670-677

DOI: 10.1016/j.jcf.2026.02.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cystic Fibrosis, 2026-07. Verfasst von Julie Semenchuk und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respirology, St. Michael's Hospital, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Cystic Fibrosis, COVID-19, Organ Transplantation. Die Arbeit nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cystic fibrosis (CF) transplant recipients infected with SARS-CoV-2 are at high risk for hospitalization or death. We aimed to (1) assess whether time since solid organ transplantation impacts severity of SARS-CoV-2 infection and (2) to evaluate the impact of SARS-CoV-2 infection on the slope of lung function trajectory. METHODS: This is a retrospective international cohort study of individuals with CF post-solid organ transplant with a confirmed SARS-CoV-2 infection between January 2020 and December 2021. The primary outcome was death or hospitalization. The secondary outcome was change in lung function trajectory following infection. To assess the impact of time from transplant on the primary outcome, logistic regression was performed while lung function trajectory was assessed using a linear mixed-effects model. RESULTS: A total of 526 SARS-CoV-2 infections from 19 countries were recorded. The median age at time of infection was 36 years (IQR 29-44). Median time since transplant was 5.8 years (IQR 3.3-10.8). The timing of transplant relative to infection was not significantly associated with hospitalization or death (OR 0.975 CI 0.928-1.025). A higher baseline ppFEV1 was associated with a decreased odds of death or hospitalization (OR 0.989, 95% CI 0.983, 0.995). In a subgroup of participants, lung function trajectory did not change significantly in the year following SARS-CoV-2 infection. CONCLUSIONS: In a diverse global post-transplant CF population, the timing of transplantation was not significantly associated with severe outcomes following SARS-CoV-2 infection. Those with more severe lung disease were at increased risk for worse outcomes and should be monitored closely.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisCOVID-19Organ TransplantationHumansFemaleRetrospective StudiesMaleAdultSARS-CoV-2HospitalizationRespiratory Function Tests

Stichwörter der Autor:innen

COVID-19Cystic fibrosisPandemic, SARS-CoV-2, CoronavirusTransplantation

Autor:innen und Institutionen

  • Department of Respirology, St. Michael's Hospital, Toronto, Ontario, Canada.
  • Cystic Fibrosis Trust, London, United Kingdom.
  • Royal Brompton and Harefield Hospitals, part of Guy's and St Thomas's NHS Foundation Trust and Imperial College, London, United Kingdom.
  • Cardiff and Vale University Health Board, Cardiff, UK.
  • Cystic Fibrosis Canada, Toronto, Canada.
  • Cystic Fibrosis Foundation, Bethesda, MD, USA.

Zitieren

APA

Semenchuk, J., Naito, Y., Charman, S. C., Carr, S. B., Duckers, J., Cheng, S. Y., Marshall, B. C., Faro, A., Elbert, A., Goss, C. H., Burgel, P. R., Colombo, C., Salvatore, M., Kashirskaya, N., Kirwan, L., Middleton, P. G., Naehrlich, L., Pastor-Vivero, M. D., Jung, A., …, & Global CF Registry Collaboration (2026). Outcomes of SARS-CoV-2 infection post-solid organ transplantation in the cystic fibrosis population. Journal of Cystic Fibrosis, 25(4), 670-677. https://doi.org/10.1016/j.jcf.2026.02.009

Vancouver

Semenchuk J, Naito Y, Charman SC, Carr SB, Duckers J, Cheng SY, et al. Outcomes of SARS-CoV-2 infection post-solid organ transplantation in the cystic fibrosis population. Journal of Cystic Fibrosis. 2026;25(4):670-677. doi:10.1016/j.jcf.2026.02.009

BibTeX
@article{Semenchuk2026,
  author = {Semenchuk, Julie and Naito, Yumi and Charman, Susan C and Carr, Siobhán B and Duckers, Jamie and Cheng, Stephanie Y and Marshall, Bruce C and Faro, Albert and Elbert, Alexander and Goss, Christopher H and Burgel, Pierre-Régis and Colombo, Carla and Salvatore, Marco and Kashirskaya, Nataliya and Kirwan, Laura and Middleton, Peter G and Naehrlich, Lutz and Pastor-Vivero, Maria Dolores and Jung, Andreas and Bakkeheim, Egil and Zolin, Anna and Orenti, Annalisa and Zomer-van Ommen, Domenique D and Zampoli, Marco and Stephenson, Anne L and Global CF Registry Collaboration, Global CF Registry Collaboration},
  title = {Outcomes of SARS-CoV-2 infection post-solid organ transplantation in the cystic fibrosis population},
  journal = {Journal of Cystic Fibrosis},
  year = {2026},
  volume = {25},
  number = {4},
  pages = {670--677},
  doi = {10.1016/j.jcf.2026.02.009}
}
Kostenlos starten →